Salesforce
CRM
$153.42
+2.20%
Salesforce, Inc. is a global leader in enterprise cloud computing, providing a comprehensive suite of customer relationship management (CRM) solutions and a platform for building business applications. The company is the dominant market leader in the CRM software space, distinguished by its Customer 360 platform that integrates data across sales, service, marketing, commerce, and analytics to create a unified view of the customer. The current investor narrative is intensely focused on the company's strategic pivot to capitalize on the AI boom, its aggressive capital return program including a massive $27 billion share repurchase plan, and navigating a challenging macroeconomic environment that has pressured software valuations despite strong underlying fundamentals.…
CRM
Salesforce
$153.42
Related headlines
Investment Opinion: Should I buy CRM Today?
Rating & Thesis: Hold. Salesforce presents a high-conviction value opportunity for long-term investors based on its depressed forward valuation and fortress fundamentals, but the severe technical downtrend and lack of a clear catalyst warrant patience before establishing new positions. This aligns with a mixed analyst sentiment that includes both Buy and Neutral ratings, with an implied average target offering ~17% upside.
Supporting Evidence: The recommendation is supported by four key data points: 1) The forward P/E of 9.77x is deeply discounted versus history and sector, 2) Robust profitability is intact with net margins expanding to 17.35%, 3) The balance sheet is exceptionally strong with a 0.29 D/E ratio and $14.4B FCF enabling the $27B buyback, and 4) The stock trades just 5% above its 52-week low, suggesting significant pessimism is already priced in. However, these are counterbalanced by the -41.51% 1-year price decline and the -22.32% 3-month drop, indicating powerful selling momentum.
Risks & Conditions: The two biggest risks are a breakdown below $149.8 support triggering further technical selling, and a deceleration of revenue growth below 10% YoY, which would challenge the growth narrative. This Hold rating would upgrade to a Buy if the stock demonstrates a confirmed technical reversal by reclaiming and holding above the $180-$200 resistance zone on strong volume, or if next quarter's earnings show re-accelerating revenue growth above 13% YoY. It would downgrade to a Sell on a sustained break below $149.8 coupled with a guidance cut. Relative to its own history and considering its growth profile, the stock is fairly valued to slightly undervalued on a forward earnings basis, but remains overvalued on a trailing basis until earnings catch up to expectations.
Sign up to view all
CRM 12-Month Price Forecast
The AI assessment is neutral based on a conflict between compelling value and broken momentum. The forward valuation is deeply attractive for a company of Salesforce's quality and cash generation, suggesting limited further fundamental downside. However, the stock is a technical 'falling knife' with severe underperformance and no visible catalyst for a near-term reversal. The stance would upgrade to bullish on a confirmed technical reversal above $180, signaling institutional accumulation and a break in the downtrend. It would turn bearish if the stock breaks below $149.8 on high volume, indicating a new leg down in the corrective phase. The high-conviction buyback program provides a long-term tailwind, but timing the entry remains the critical challenge.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Salesforce's 12-month outlook, with a consensus price target around $199.45 and implied upside of +30.0% versus the current price.
Average Target
$199.45
11 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
11
covering this stock
Price Range
$123 - $199
Analyst target range
Analyst coverage for Salesforce is extensive, with 19 analysts providing estimates, reflecting its status as a large-cap institutional staple. The consensus sentiment, based on recent institutional ratings, appears cautiously optimistic to neutral, with firms like Needham, Stifel, TD Cowen, JP Morgan, and Piper Sandler maintaining Buy or Overweight ratings, while others like Citigroup, Macquarie, and Wells Fargo hold Neutral or Equal Weight stances. The average target price must be inferred from estimated EPS and revenue; with an average estimated EPS of $18.17 and using the forward PE of 9.77x, the implied consensus price target is approximately $177.50, suggesting a potential upside of nearly 17% from the current price of $151.78. The target range, derived from estimated EPS, spans from a low of $17.86 to a high of $18.75. Applying the forward PE multiple, this implies a price range from roughly $174.50 to $183.20. The high target likely assumes successful execution on AI monetization, sustained margin expansion, and effective capital deployment through buybacks. The low target likely factors in risks like macroeconomic headwinds impacting software spending, competitive pressures, and potential integration challenges from acquisitions. The relatively tight range among analysts indicates stronger conviction in near-term earnings estimates, but the wide disparity in stock price targets from various firms (not provided in data) would signal uncertainty about the appropriate multiple to apply in a volatile market.
Bulls vs Bears: CRM Investment Factors
The investment debate for Salesforce is a classic clash between deteriorating price momentum and deteriorating sentiment versus a fundamentally strong and cash-generative business trading at a historically depressed valuation. Currently, the bearish technical picture and macro headwinds hold stronger near-term evidence, as reflected in the stock's 41% annual decline and severe underperformance. However, the bullish fundamental case—anchored by a fortress balance sheet, aggressive capital return, and a forward P/E of just 9.77x—presents a compelling counter-argument for patient investors. The single most important tension is whether the company's strategic AI pivot and massive buyback program can successfully reignite growth expectations and investor confidence before technical breakdowns trigger further capitulation. The resolution of this tension—specifically, the next quarter's revenue growth trajectory and margin performance—will determine the direction of the stock.
Bullish
- Fortress Balance Sheet & Massive Buyback: Salesforce has a robust financial position with a low debt-to-equity ratio of 0.29 and generated $14.4 billion in TTM free cash flow. This underpins the aggressive $27 billion share repurchase program, which signals strong management confidence and provides significant EPS accretion potential.
- Strong Profitability & Margin Expansion: The company maintains excellent gross margins of 77.61% and has demonstrated expanding profitability. Net income grew from $1.71B to $1.94B year-over-year in Q4, with the net margin improving from 17.09% to 17.35%, showcasing disciplined cost management.
- Attractive Forward Valuation: The stock trades at a forward P/E of only 9.77x, a significant discount to its trailing P/E of 27.05x and typical SaaS multiples. This implies the market is pricing in a sharp earnings acceleration, potentially driven by AI integration and buybacks, offering a compelling entry point.
- Implied Upside to Analyst Targets: Using the average estimated EPS of $18.17 and the forward P/E of 9.77x, the implied consensus price target is approximately $177.50. This represents a potential upside of nearly 17% from the current price of $151.78, suggesting the stock is undervalued by analysts.
Bearish
- Severe Technical Downtrend & Underperformance: The stock is in a pronounced downtrend, down 41.51% over the past year and trading just 5% above its 52-week low of $149.8. It has severely underperformed the S&P 500, with a -37.46% relative strength over 3 months, indicating intense sector-specific selling pressure and a lack of near-term catalysts.
- Revenue Growth Deceleration: While Q4 revenue grew 12.09% YoY to $11.20B, the sequential quarterly growth trend has moderated. This deceleration, in a challenging macro environment for software spending, raises concerns about the company's ability to sustain high growth rates to justify its valuation premium.
- High Trailing P/E & Valuation Compression Risk: The trailing P/E of 27.05x remains above typical SaaS industry averages, suggesting a premium. In an environment where inflation risk is capping equity multiples (per recent news), this premium is vulnerable to compression if growth expectations are not met.
- Sector Rotation & Macro Headwinds: Recent market dynamics show a powerful rotation into AI infrastructure and semiconductor stocks, while software names like Salesforce have pulled back. Sticky inflation and a hawkish Fed, as noted in news, continue to pressure valuations for growth-oriented software companies.
CRM Technical Analysis
The stock is in a pronounced and sustained downtrend, with a 1-year price change of -41.51% and a 6-month decline of -41.60%, significantly underperforming the broader market. As of the latest close of $151.78, the stock is trading near the bottom of its 52-week range, approximately 5% above its 52-week low of $149.8 and 45% below its 52-week high of $276.8. This positioning near multi-year lows suggests the market is pricing in severe pessimism, presenting a potential deep-value opportunity, though the persistent selling pressure indicates it remains a 'falling knife' scenario with high risk of further declines. Recent momentum shows severe weakness, with the stock down -15.41% over the past month and -22.32% over the past three months, starkly diverging from the S&P 500's gains of +0.74% and +15.14% over the same periods, respectively. This extreme negative relative strength of -16.15% (1-month) and -37.46% (3-month) highlights intense sector-specific selling pressure and a complete breakdown in price support. The divergence from the longer-term downtrend is not a reversal but an acceleration of the bearish move, signaling capitulation and a lack of near-term catalysts. Key technical levels are clearly defined, with immediate support at the 52-week low of $149.8 and major resistance at the 52-week high of $276.8. A decisive breakdown below $149.8 would likely trigger another wave of selling, while any sustainable recovery would need to reclaim the $200 psychological level first. The stock's beta of 1.151 indicates it is approximately 15% more volatile than the broader market, which, combined with a maximum drawdown of -47.87%, underscores the heightened risk profile and necessitates careful position sizing for investors considering an entry.
Beta
1.15
1.15x market volatility
Max Drawdown
-47.9%
Largest decline past year
52-Week Range
$146-$277
Price range past year
Annual Return
-41.8%
Cumulative gain past year
| Period | CRM Return | S&P 500 |
|---|---|---|
| 1m | -14.8% | -1.6% |
| 3m | -15.7% | +11.7% |
| 6m | -42.2% | +6.3% |
| 1y | -41.8% | +22.2% |
| ytd | -39.5% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CRM Fundamental Analysis
Revenue growth remains robust but is showing signs of sequential deceleration. The most recent quarterly revenue (Q4 FY2026) was $11.20 billion, representing a solid 12.09% year-over-year growth. However, examining the quarterly trend reveals a slowdown: revenue grew from $9.13B (Q1 FY2025) to $11.20B (Q4 FY2026), but the sequential quarter-over-quarter increases have moderated. Segment data shows balanced contributions, with Service Cloud ($2.53B) and the Salesforce Platform ($2.66B) as the largest revenue drivers, indicating the company's expansion beyond its core Sales Cloud ($2.33B) is successful. Profitability is strong and margins are healthy. The company reported net income of $1.94 billion for Q4 FY2026, with a net margin of 17.35%. Gross margin remains excellent at 77.61%, consistent with its high-margin software business model. Operating margin for the quarter was 21.88%, demonstrating efficient scaling. The trend shows profitability is intact; comparing to the year-ago Q4 (Jan 2025), net income has grown from $1.71B to $1.94B, and the net margin expanded from 17.09% to 17.35%, signaling disciplined cost management amidst growth. The balance sheet is a fortress, characterized by massive cash generation and a conservative capital structure. Trailing twelve-month free cash flow is a substantial $14.40 billion, providing ample internal funding for growth and shareholder returns. The debt-to-equity ratio is a low 0.29, indicating minimal financial leverage and low risk. Return on equity is a respectable 12.61%, and the company ended its last quarter with $7.33 billion in cash. This financial strength underpins the aggressive $27 billion share repurchase program announced recently, signaling management's confidence in intrinsic value.
Quarterly Revenue
$11.2B
2026-01
Revenue YoY Growth
+0.12%
YoY Comparison
Gross Margin
+0.77%
Latest Quarter
Free Cash Flow
$14.4B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CRM Overvalued?
Given the company's consistent profitability (Net Income > 0), the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 27.05x, while the forward PE is significantly lower at 9.77x. This substantial gap implies the market is pricing in a sharp acceleration in earnings growth, likely driven by expectations for margin expansion from AI integration, cost discipline, and the impact of massive share buybacks. Compared to the broader software industry, Salesforce's valuation presents a mixed picture. Its trailing PE of 27.05x is above typical SaaS averages, which often range in the low 20s, suggesting a premium. However, its Price-to-Sales ratio of 4.86x and EV-to-Sales of 3.81x are more reasonable for a mature, profitable software leader. The premium on the PE multiple can be partially justified by its industry-leading position, robust cash flows, and the strategic pivot to AI, but it also reflects high expectations that must be met to sustain the valuation. Historically, the stock's current trailing PE of 27.05x sits well below its own historical range observed in recent quarters, which has seen peaks above 40x and even 245x during periods of minimal earnings. Compared to its PE of 25.54x at the end of January 2026, the current multiple is slightly higher despite a much lower stock price, indicating earnings have declined faster than the price. Trading near the lower end of its historical valuation band suggests the market has already priced in significant pessimism, potentially limiting further multiple compression if fundamentals stabilize.
PE
27.0x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -2046x~1557x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Salesforce's primary financial risk is not leverage or cash burn—its balance sheet is a fortress with a 0.29 debt-to-equity ratio and $14.4B in TTM FCF—but rather its dependence on sustaining high revenue growth to justify its valuation premium. The trailing P/E of 27.05x, while below its historical peaks, still implies robust future earnings growth. The observed sequential deceleration in revenue growth, from a quarterly run rate, poses a risk if it trends toward the low double-digits, potentially compressing the multiple further. Furthermore, the success of its massive $27B buyback program is contingent on continued strong cash generation, which could be pressured by an economic downturn impacting corporate IT budgets.
Market & Competitive Risks: The stock faces significant market risk from valuation compression, as it trades at a premium to many software peers on a trailing earnings basis. Recent news highlights that 'inflation risk is still capping equity multiples,' creating a hostile environment for richly valued growth stocks. Competitively, while Salesforce is the CRM market leader, the sector is intensely competitive, and its AI pivot must successfully monetize to fend off challenges from broader platform players and specialized AI startups. The stock's beta of 1.151 indicates it is 15% more volatile than the market, amplifying downside moves during sector-wide selloffs, as evidenced by the -37.46% 3-month relative strength versus the S&P 500.
Worst-Case Scenario: The worst-case scenario involves a continuation of the current macro headwinds capping software valuations, coupled with a sharper-than-expected slowdown in enterprise spending leading to a revenue growth miss and guidance cut. This could trigger a loss of investor confidence, leading to a breakdown below the key $149.8 support (the 52-week low), initiating a wave of stop-loss selling and analyst downgrades. Given the stock's -47.87% maximum drawdown and current proximity to its low, a realistic downside scenario could see a re-test and break below $149.8, potentially driving the stock toward the $130-$140 range, representing a further -10% to -15% decline from current levels. The aggressive buyback might slow the descent but likely not reverse a fundamental deterioration in sentiment.
FAQ
The key risks are, in order of severity: 1) Technical & Momentum Risk: The stock is in a pronounced downtrend (-41.51% YOY) and a break below the $149.8 support could trigger accelerated selling. 2) Growth Deceleration Risk: Revenue growth, while still at 12.09% YoY, has shown signs of sequential moderation; a drop into single digits would severely challenge the investment thesis. 3) Valuation Compression Risk: The trailing P/E of 27.05x remains elevated and is vulnerable to compression in a high-interest rate environment, as recent news highlights inflation capping equity multiples. 4) Sector Rotation Risk: Market funds are rotating into AI infrastructure and semiconductors, leaving enterprise software like CRM behind, as evidenced by its -37.46% 3-month relative strength.
The 12-month forecast for CRM is a wide range reflecting high uncertainty, with a base case target of $165-$180 (8-18% upside), a bull case target of $183-$200 (20-31% upside), and a bear case target of $140-$155 (-8% to -2% return). The base case, assigned a 50% probability, assumes the company executes in line with current expectations, delivering low double-digit revenue growth and stable margins, allowing the stock to grind higher as earnings grow into its low forward multiple. The most likely outcome is this base case, but the stock's path will be heavily influenced by the next few quarterly earnings reports and broader macro conditions impacting software valuations.
CRM's valuation is bifurcated. On a trailing basis, with a P/E of 27.05x, it trades at a premium to many software peers and could be considered overvalued if growth decelerates. However, on a forward basis, the P/E of 9.77x is deeply discounted and suggests the stock is significantly undervalued if the company meets its estimated EPS of $18.17. This gap implies the market is pricing in a substantial earnings acceleration. Compared to its own historical valuation range, the stock is near the lower end, indicating pessimism is largely priced in. Overall, the forward multiple suggests the stock is fairly valued to undervalued, but this is contingent on the company delivering on high earnings growth expectations.
CRM is a complex buy at current levels. For long-term, patient investors, the forward P/E of 9.77x and fortress balance sheet present a compelling value proposition for a market-leading software company, with an implied 17% upside to analyst targets. However, it is not a good buy for short-term traders or risk-averse investors, as the stock is in a severe technical downtrend, down 41.51% over the past year, and remains vulnerable to further sector-wide selling. The most suitable buyer is one who believes in the company's long-term AI strategy and is willing to average in over time, acknowledging the risk of further declines toward the $149.8 support level.
CRM is unequivocally suitable only for long-term investment given its current state. The stock's high beta (1.151), severe downtrend, and lack of near-term catalysts make it a poor candidate for short-term trading. The investment thesis is based on the company's fundamental strength, AI transition, and capital return program playing out over several years. A long-term horizon (3-5 years) allows investors to look through the current technical and sentiment weakness and benefit from the deeply discounted forward valuation. There is no dividend to support short-term holders (yield is 0.79%). Therefore, a minimum holding period of 18-24 months is suggested to allow for a potential business cycle and sentiment recovery.